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ABSTRACT 
Purpose: An ideal commissioning and quality assurance (QA) program for Volumetric Modulated 
Arc Therapy (VMAT) delivery systems should assess the performance of each individual dynamic 25 
component as a function of gantry angle. Procedures within such a program should also be time-
efficient, independent of the delivery system and be sensitive to all types of errors. The purpose of this 
work is to develop a system for automated time-resolved commissioning and QA of VMAT control 
systems which meets these criteria. 
Methods: The procedures developed within this work rely solely on images obtained using an 30 
electronic portal imaging device (EPID) without the presence of a phantom. During the delivery of 
specially designed VMAT test plans, EPID frames were acquired at 9.5 Hz using a frame grabber. 
The set of test plans was developed to individually assess the performance of the dose delivery and 
multileaf collimator (MLC) control systems under varying levels of delivery complexities. An in-
house software tool was developed to automatically extract features from the EPID images and 35 
evaluate the following characteristics as a function of gantry angle: dose delivery accuracy, dose rate 
constancy, beam profile constancy, gantry speed constancy, dynamic MLC positioning accuracy, 
MLC speed and acceleration constancy, and synchronisation between gantry angle, MLC positioning 
and dose rate. Machine log files were also acquired during each delivery and subsequently compared 
to information extracted from EPID image frames.  40 
Results: The largest difference between measured and planned dose at any gantry angle was 0.8% 
which correlated with rapid changes in dose rate and gantry speed. For all other test plans the dose 
delivered was within 0.25% of the planned dose for all gantry angles. Profile constancy was not found 
to vary with gantry angle for tests where gantry speed and dose rate were constant, however, for tests 
with varying dose rate and gantry speed, segments with lower dose rate and higher gantry speed 45 
exhibited less profile stability. MLC positional accuracy was not observed to be dependent on the 
degree of interdigitation. MLC speed was measured for each individual leaf and slower leaf speeds 
were shown to be compensated for by lower dose rates. The test procedures were found to be sensitive 
to 1 mm systematic MLC errors, 1 mm random MLC errors, 0.4 mm MLC gap errors and 
synchronisation errors between the MLC, dose rate and gantry angle controls systems of 1˚. In 50 
general, parameters measured by both EPID and log files agreed with the plan however a greater 
average departure from the plan was evidenced by the EPID measurements. 
Conclusion: QA test plans and analysis methods have been developed to assess the performance of 
each dynamic component of VMAT deliveries individually and as a function of gantry angle. This 
methodology relies solely on time-resolved EPID imaging without the presence of a phantom and has 55 
been shown to be sensitive to a range of delivery errors. The procedures developed in this work are 
both comprehensive and time-efficient and can be used for streamlined commissioning and QA of 
VMAT delivery systems.  
 
  60 
I. INTRODUCTION 
Volumetric-modulated arc therapy (VMAT) is a modern radiotherapy delivery technique where an 
external beam of radiation is delivered during continuous gantry rotation. Highly conformal 3D dose 
distributions are delivered by dynamically shaping the radiation beam using a multi-leaf collimator 
(MLC) and through continuous modulation of the dose rate (DR) and gantry speed (GS).1, 2 Compared 65 
to intensity-modulated radiation therapy (IMRT),3 where the gantry is static during dose delivery, 
VMAT requires fewer monitor units (MU) and generally shorter treatment times to achieve an 
equivalent dose distribution.2, 4  A potential disadvantage for VMAT is the added complexity related 
to more intricate dynamic MLC trajectories, DR modulation and changes in GS.  
Due to this high level of complexity there is a need for more comprehensive linear accelerator (linac) 70 
commissioning and quality assurance (QA) techniques to properly assess the performance of the 
individual VMAT control systems. One challenge for VMAT commissioning and QA systems is the 
ability to assess the synchronisation of each of the 3 dynamic components (i.e. the MLC, DR and GS). 
It is also essential that commissioning and QA programs are independent of the linac control system, 
time-efficient enough to perform on a regular basis and have the ability not only to detect errors but 75 
also to determine their source.  
Commissioning and QA procedures specific to VMAT delivery systems have been proposed using 
integrated images from an electronic portal imaging device (EPID).5-10 The most commonly applied 
procedures for the Varian RapidArc platform (Varian Medical Systems, Palo Alto, CA) were 
developed by Ling et al.5 who proposed tests designed to evaluate the performance of the linac 80 
delivery system in a step-wise manner. Tests were designed to assess MLC positioning during gantry 
rotation, dose delivery accuracy under different DR and GS conditions, and dose delivery accuracy 
for different combinations of MLC speed and DR. These procedures are stated by the authors to be 
“an initial attempt in designing a commissioning and QA protocol” and are subject to some 
limitations. Firstly, the synchronisation between the MLC, DR and gantry angle is not assessed and 85 
quantified within this set of tests.11 As a result, no measurements are performed to verify that the 
MLCs are at the correct position at the intended gantry angle or that the correct dose is delivered at 
the intended gantry angle. Secondly, due to the limitations associated with using integrated 
measurement devices (e.g. film or integrated MV images) the control systems cannot be assessed 
individually and hence their accuracy cannot be quantified in isolation. As a result, it is not possible to 90 
identify the source of any detected errors or monitor the performance of each control system 
separately over time.  
Van Esch et al. 6 developed a set of tests which focused specifically on verifying that the monitor 
units (MU) and MLC positions are correctly synchronised with gantry angle. These tests utilise film 
placed trans-axially within a phantom positioned at the linac isocentre. Whilst these tests address 95 
some of the limitations associated with non-gantry resolved QA measurements, the use of film can be 
time consuming and labour intensive thereby limiting the ability to apply these procedures on a 
regular basis. Van Esch et al. also designed a more streamlined test which relies on a single integrated 
EPID image to assess the combined interplay between MLC position, dose delivery and gantry angle.  
While this test is time-efficient, it has the disadvantage that the performance of each control system is 100 
convolved into a single measurement, hence MLC and dose control cannot be assessed and monitored 
individually. Another disadvantage is that gantry angle synchronisation is not evaluated as the EPID 
rotates with the linac and images are averaged over large 90˚ arc segments. 
A number of procedures have been proposed which rely on detector arrays within commercial QA 
phantoms for VMAT-specific linac QA.12-14 Wang et al. developed a methodology which utilises a 105 
helical diode array and custom QA plan for routine linac QA.14 This methodology was shown to be 
very efficient, however the use of diode array devices for this purpose is limited by the spatial 
resolution of the two-dimensional detector array, particularly for QA of the dynamic MLC. Barnes et 
al.12, 13 developed methodologies for QA of DR and profile constancy as a function of gantry angle 
using time-resolved measurements from a 2D ion chamber array. The main disadvantage of this 110 
approach is that the same device cannot be used to assess MLC performance during VMAT due to the 
inadequate spatial resolution of the detector array. The authors also state that the use of a more 
universally available and applicable device, such as the EPID, would be more suited to perform these 
procedures.  
One popular approach to treatment delivery system quality control is the use of machine log files (e.g. 115 
Varian Dynalog files).5, 15-22 Machine log files offer a number of advantages such as the ability to 
streamline and automate QA processes however, a number of recent studies have shown that log files 
are insensitive to some types of delivery errors.16, 23, 24 This insensitivity arises from the fact that the 
parameters recorded by log files (i.e. MLC positions, gantry angle and dose fraction) are sourced from 
the linac control system itself and hence are not independent measurements. This was demonstrated 120 
by Agnew et al.16 who showed that Varian Dynalog files were not sufficient to detect MLC leaf 
calibration errors and backlash. Similar observations were made by, Niel et al.24 who reported on 
systematic differences between log file derived MLC positions and actual MLC positions greater than 
1 mm during a clinical delivery. 
The use of integrated EPID imaging for linear accelerator QA has a number of advantages, including 125 
high spatial resolution, large detector size and minimal setup time. EPID imaging is also available on 
all major commercially available linear accelerators and image acquisition can be easily automated 
within the treatment delivery system. Despite these clear advantages, integrated imaging is 
fundamentally limited as it cannot be used to directly measure the MLC positions, DR and GS as a 
function of time during the delivery. Accessing the individual EPID image frames, rather than a single 130 
integrated EPID image, allows direct measurement of these time-varying components without 
compromising the efficiency of the procedure. A number of groups have investigated the use of time-
resolved EPID imaging for linac QA25-31 and plan-specific QA25, 32-36 for IMRT and VMAT deliveries. 
Zwan et al.25 developed a system to automatically extract MLC trajectories from EPID image frames 
which could be subsequently compared to the planned MLC positions in order to calculate MLC 135 
positioning errors for each individual leaf as a function of gantry angle. This methodology was tested 
using clinical prostate and head and neck VMAT plans for plan-specific MLC QA but was not used in 
conjunction with a suitable QA test plan for linac QA purposes.  
There is widespread consensus in the medical physics community that the available tests for VMAT-
specific linac QA are insufficient resulting in a dependence on patient specific QA.5, 6, 12-14, 25, 26, 36 140 
Many of the challenges associated with quality control of VMAT are addressed in the most recent 
report from the Netherlands Commission on Radiation Dosimetry (NCS Report 24)37, who  make 
recommendations for VMAT-specific linear accelerator QA and commissioning. Since the release of 
this report, no work has been done to develop a single system which systematically addresses all of 
these recommendations. 145 
The aim of this work is to develop a comprehensive and time-efficient system for commissioning and 
QA of VMAT delivery systems which assesses the performance of each individual dynamic machine 
component as a function of gantry angle. EPID image frames are acquired at 9.5 frames-per-second 
without the presence of a phantom during the delivery of a set of custom-designed QA test plans. 
From these acquired images, MLC positioning accuracy, dose delivery accuracy, profile constancy, 150 
DR constancy and GS constancy were assessed as a function of gantry angle. This QA methodology is 
independent of the delivery system as it relies solely on EPID images taken without a phantom or 
external detector. Image acquisition and analysis has been fully automated to streamline the QA 
procedure. This system has the ability not only to detect errors, but also to differentiate between each 
component of the delivery and determine at what point in the delivery the component failed. This 155 
work details the first set of procedures specifically designed to assess all components of VMAT 
deliveries as a function of gantry angle relying solely on time-resolved EPID imaging. 
II. MATERIALS AND METHODS 
II.A.  Overview of method 
The methodology developed for commissioning and QA of VMAT delivery systems can be 160 
summarised in Figure 1 below. This process includes (1) the delivery of 7 VMAT test plans, (2) 
acquisition of EPID image frames during these deliveries without the presence of a phantom, (3) 
automatic image analysis to directly measure dosimetric and MLC parameters and (4) comparison of 
measured parameters to the DICOM plan, machine log files and baseline data as a function of gantry 
angle. 165 
 Figure 1: Overview of methodology developed for VMAT QA and commissioning. 
II.B.  Delivery systems and image acquisition 
The procedures developed in this study were tested using a Varian 2100 IX linac (Varian Medical 
Systems, Palo Alto, CA) for a 6 MV photon beam. This treatment unit was equipped with a 170 
Millennium 120 leaf MLC which has a 5 mm and 10 mm leaf width for the central and outer leaves 
respectively. EPID images were collected using an aS1000 EPID which was operated in integrated 
mode and has a pixel size of 0.392×0.392 mm2. All images were acquired with a source to detector 
distance (SDD) of 100 cm and were automatically flood field and dark field corrected. Individual 
EPID image frames were collected at a rate of 9.5 frames per second using an ancillary PC equipped 175 
with a dual-channel frame grabber system and in-house acquisition software. The gantry angle from 
the OBI gantry angle encoder was tagged to the header of each acquired image frame.25, 36 The gantry 
angle naming convention used by this system and subsequently throughout this work, is 0˚ = 0˚IEC, 90˚ 
= 90˚IEC, 179˚ = 179˚IEC, -90˚ = 270˚IEC and -179˚ = 181˚IEC relative to IEC 61217 (2008) scale.  
II.C.  Image analysis techniques 180 
A set of test plans was designed to stress test various components of the delivery system during 
VMAT. Two categories of plans were created (1) dosimetry test plans and (2) MLC test plans. The 
dosimetry test plans rely on static jaw-defined fields without in-field MLC motion whilst the MLC 
test plans incorporated dynamic MLC trajectories. 
II.C.1. Image analysis for dosimetry test plans 185 
The following machine parameters were extracted from each individual EPID frame during delivery 
of the dosimetry test plans: MU, DR, X profile (transverse), Y profile (radial), gantry angle and GS. 
The MU per frame was measured by calculating the average pixel value from the central 1×1 cm2 
region of the EPID. This was subsequently converted to MU using a pixel-to-MU conversion factor 
which was determined by delivering a 100 MU calibration field at 0˚ gantry angle with the same field 190 
size and SDD as the test plan deliveries. Equation 1 below details the conversion of the pixel values in 
each frame, Sframe, to MU where Sint,100MU is the central axis pixel value for an integrated EPID image 
of a 100 MU delivery. 
ܯܷ ݌݁ݎ ݂ݎܽ݉݁ = ௙ܵ௥௔௠௘ × ቈ
100 ܯܷ
௜ܵ௡௧,ଵ଴଴ெ௎
቉ 
Using the MU per frame the cumulative MU could be calculated by summing the MU for all previous 
frames. The DR (in MU/min) per frame could then be determined using the known integration time of 195 
each image frame. The measured cumulative MU versus gantry angle was subsequently compared to 
the control points of the DICOM plan file for each test plan. 
X and Y profiles through the central axis were also extracted from each EPID image frame. The beam 
profiles were averaged every 10 frames (approximately every second) and compared to baseline beam 
profiles acquired from a 100 MU integrated EPID image with a static gantry at 0˚. Off-axis ratios 200 
(OAR) for the central 80% of the field in the X and Y direction were used as the metric to compare 
the profiles at each gantry angle to the baseline. The maximum percentage change in any given X and 
Y off-axis ratio was reported as a function of gantry angle. Note that the 10-frame averaging was 
required as the EPID image is read out in the Y-direction as a function of time. Therefore, any rapid 
changes in DR during the readout of a single frame is reflected within the beam profile in the Y 205 
direction.38 Averaging of 10 frames was chosen as a compromise to average out this effect without 
unnecessary reduction in the gantry angle resolution.  
The GS was computed as a function of time during each delivery using the gantry angle and time 
stamp in the EPID image frame header. 
II.C.2  Image analysis for MLC test plans 210 
For each MLC test plan, the MLC positions were extracted from each EPID image frame using the 
methodology outlined in Zwan et al.25 In this process, collimator rotation is removed and correction 
are made for MLC, gantry and image panel sag using a measured sag map in order to precisely extract 
the profile through the centre of each leaf pair. The radiation field edge can then be detected for each 
in-field MLC leaf and corrected for transmission through the curved leaf tip to give the light field 215 
edge position, i.e. the geometric leaf position39 which is specified in the DICOM plan file. 
Once the MLC positions were determined the MLC position error could be calculated for each 
individual MLC leaf as a function of gantry angle by comparing the measured MLC positions to the 
control points of the DICOM plan file. Note that the MLC control system attempts to produce linear 
MLC motion between control points40 and so linear interpolation was used to determine the planned 220 
MLC positions at each EPID frame in between control points. Using the measured MLC positions 
from each frame, the leaf speed, leaf acceleration and leaf-pair gap error for each leaf could be 
calculated as a function of gantry angle. 
II.D. Design of dosimetry test plans 
Four dosimetry test plans were created with varying levels of delivery complexity. The specialized 225 
plans were constructed within MATLAB® (Mathworks, Natick, MA) by manually creating a set of 
control points within the DICOM plan structure. The created DICOM files were then imported as 
VMAT plans into the treatment planning system (TPS) so that the control system during the delivery 
was identical to a RapidArc patient treatment. Unless stated otherwise, dosimetry test plans were 
delivered with a static 25×25 cm2 jaw-defined field with the MLCs retracted beyond the field edge. 230 
All dosimetry and MLC plans were constructed and delivered with both clockwise and counter-
clockwise gantry rotation. From each of these test plans the cumulative MU, DR, beam profiles and 
GS could be extracted as a function of gantry angle and compared to the planned values or to a 
baseline. 
II.D.1 Dose Test 1: constant DR and GS 235 
Dose Test 1 assesses the dosimetric performance of the delivery system during VMAT arcs with the 
lowest level of complexity, where both the GS and DR are constant throughout the delivery. The GS 
and DR were intentionally set to be at a maximum, i.e. 4.8 degrees per second and 600 MU/min 
respectively. 
II.D.2 Dose Test 2: DR and GS transitions 240 
Simultaneous changes in DR and GS were introduced into Dose Test 2 every 30˚ of gantry rotation. In 
regions between each transition the DR and GS were kept constant. This test allows calculation of the 
dosimetric performance for different combinations of constant DR and GS as well as in regions when 
these parameters are changing rapidly (Table 1). Note that there are no segments containing both low 
GS and low DR as the GS is only lowered when the DR is at a maximum.  245 
Table 1: Planned GS and DR during 30˚ segments for clockwise delivery of Dose Test 2. Maximum 
and Low DR refers to 600 MU/min and 100 MU/min respectively and Maximum and Low GS refer to 
4.8˚/s and 1.0˚/s respectively. 
Arc  Segment GS DR 
-180˚-150˚ Low Maximum 
-150˚-120˚ Maximum Low 
-120˚-90˚ Maximum Maximum 
-90˚-60˚ Low Maximum 
-60˚-30˚ Maximum Low 
-30˚0˚ Maximum Maximum 
0˚30˚ Low Maximum 
30˚60˚ Maximum Low 
60˚90˚ Maximum Maximum 
90˚120˚ Low Maximum 
120˚150˚ Maximum Low 
150˚180˚ Maximum Maximum 
 
II.D.3 Dose Test 3: dose delivery with maximum inertia 250 
Rapid transitions in GS can result in dose delivery errors, if gantry acceleration exceeds a threshold.  
Dose Test 3 was adapted from the Maximum Allowable Inertia Overshoot (MAIO) test suggested by 
the Netherlands Commission on Radiation Dosimetry (NCS Report 24).37 This test is designed to 
deliver a VMAT arc with maximum changes in inertia of the gantry and simultaneous maximum 
changes in DR. This test plan was included, not as a representative of a clinical delivery, but as the 255 
most challenging delivery that could potentially be required by the treatment unit under any 
conditions. 
II.D.4 Dose Test 4: clinical VMAT delivery 
In addition to the test plans listed previously, a clinical VMAT delivery was also included within the 
test set. This plan comprises of a dual-arc head and neck VMAT treatment which is delivered with 260 
constant GS and typical DR modulation. The planned MLC positions for this plan were retracted such 
that all MLC motion occurred behind the jaw-defined 10×10 cm2 static field. Note that each MLC leaf 
trajectory was not altered in this process, but was simply retracted by a constant amount at all control 
points so as not to obscure the jaw-defined static field. 
II.E. MLC test plans 265 
Three MLC test plans were specifically designed to evaluate the different aspects of the MLC control 
system. The complexity of the planned MLC trajectories was systematically increased for each test 
plan starting with simple sliding gap MLCs during arc rotation and building to a complex clinical 
VMAT delivery. For every MLC leaf of each test plan the MLC trajectory, positional error, gap error, 
leaf speed and leaf acceleration was measured as a function of gantry angle and compared to the 270 
planned MLC positions from the DICOM plan file. All plans were constructed with 0˚ collimator in 
order to assess the impact of gravity on MLC motion.  
II.E.1 MLC Test 1: sliding window during gantry rotation 
MLC Test 1 was designed to assess the dynamic MLC positioning accuracy for the simplest type of 
MLC motion, where there is no friction between adjacent leaves and no interdigitation. This test can 275 
be described as a series of arc segments where each segment contains a 2 cm sliding gap MLC 
pattern. The sliding gap motion of the MLC during each segment is depicted in Figure 2 (a) where all 
MLCs are moving in the same direction at the same speeds. Each segment contains the same sliding 
gap motion but with varying MLC speeds (ranging from 5 mm/s to 25 mm/s). The direction of MLC 
travel was reversed between each segment to allow bi-directional assessment of the MLCs 280 
acceleration (Table 2).  
Table 2: Planned arc segment size, MU per segment and MLC speed for each segment of MLC Test 
1. Planned MLC speeds were calculated assuming the dose is delivered at a maximum DR (600 
MU/min) throughout the plan. Each MLC bank traversed 12 cm of motion within each arc segment. 
MLC motion during retraction was denoted as positive (+) MLC speed and MLC motion during 285 
extension was denoted as negative (-) MLC speed. 
Gantry Angle 
Segment Arc Segment Size MU per Segment 
Planned MLC Speed (mm/s) 
Bank A Bank B 
176.8˚  119.2˚ 57.6˚ 240 +5 -5 
119.2˚  61.6˚ 57.6˚ 240 -5 +5 
61.6˚  42.4˚ 19.2˚ 80 +15 -15 
42.4˚  23.2˚ 19.2˚ 80 -15 +15 
23.2˚  8.8˚ 14.4˚ 60 +20 -20 
8.8˚  -5.6˚ 14.4˚ 60 -20 +20 
-5.6˚  -17.2˚ 11.5˚ 48 +25 -25 
-17.2˚  -28.6˚ 11.5˚ 48 -25 +25 
-28.6˚  -40.2˚ 11.5˚ 48 +25 -25 
-40.2˚  -51.7˚ 11.5˚ 48 -25 +25 
-51.7˚  -66.1˚ 14.4˚ 60 +20 -20 
-66.1˚  -80.5˚ 14.4˚ 60 -20 +20 
-80.5˚  -99.7˚ 19.2˚ 80 +15 -15 
-99.7˚  -118.9˚ 19.2˚ 80 -15 +15 
-118.9˚  -147.7˚ 28.8 120 +10 -10 
-147.7˚  -176.5˚ 28.8 120 -10 +10 
 
II.E.2 MLC Test 2: interdigitating sliding window during gantry rotation 
MLC Test 2 assesses the dynamic MLC performance with interdigitation. This test contains the same 
MLC trajectories, speeds and acceleration as in MLC Test 1 (see Table 2) but with alternating 290 
(odd/even) MLC leaves always travelling in opposite direction as depicted in Figure 2. This test was 
designed to simulate the highest amount of friction between adjacent MLC leaves during 
interdigitation. As with MLC Test 1 this plan incorporates a range of MLC speeds, assesses motion in 
both directions and includes changes in direction of travel between each segment. 
 295 
Figure 2: Visual representation of MLC positions at the start and end of each arc segment for (a) 
MLC Test 1: sliding window and (b) MLC Test 2: interdigitating sliding window. The trajectories are 
repeated in different segments using varying MLC speeds and direction of MLC motion as described 
in Table 2. 
II.E.3 MLC Test 3: clinical VMAT delivery  300 
MLC performance during a dual-arc clinical Head and Neck VMAT plan was also evaluated. This test 
is limited in that it does not assess accuracy of all MLC leaves equally, however, it does provide an 
overall assessment of the MLC control system during an actual clinical delivery which incorporates 
changes in DR, a range of MLC speeds and accelerations, varying gap widths and collimator rotation.  
II.F.  Machine log file analysis 305 
Machine log files (Varian Dynalog files) were also obtained during the delivery of each dosimetry and 
MLC test plan in order to compare the EPID-measured parameters with those recorded by the linac 
control system.  
For the dosimetry test plans, the gantry angle, GS, DR and cumulative MU were extracted at 50 ms 
intervals from the log files. As dose fraction is recorded in the log file rather than the absolute dose 310 
output, the dose fraction was subsequently converted to absolute DR and cumulative MU by assuming 
the correct total MU was delivered. Note that, in order for the linac to record Varian Dynalog files 
some MLC motion is required. To enable the acquisition of Dynalog files for the dosimetry plans 
(where there is no MLC motion within the field) a single MLC was moved behind the jaws during the 
delivery.  315 
For the MLC test plans, the MLC positions were extracted and compared to the corresponding EPID-
measurements and the planned MLC positions. All log file MLC positions were post-processed to 
remove the leaf position offset (LPO) correction prior to any comparisons.25, 39 
II.G.  Clinical implementation 
All test plans used in this study were imported into a single QA patient within an Eclipse TPS 320 
(Version 11.031, Varian Medical Systems) and delivered in clinical mode. An in-house software tool 
was developed using MATLAB® to automatically analyse the acquired data, compare the 
measurements to the DICOM plan file and save the results in graphical and quantitative format. This 
tool was equipped with a graphical user interface which was designed to streamline the QA process. 
III. RESULTS 325 
III.A.  Dosimetry test results 
III.A.1 Output verification during VMAT 
Figure 3 shows the measured error in relative dose delivered as a function of gantry angle for (a) Dose 
Test 1, (b) Dose Test 2, (c) Dose Test 3 and (d) Dose Test 4. Percentage errors were computed by 
comparing the MU measured from EPID images (MUMeas) to the MU from the DICOM plan file 330 
(MUPlan). The relative dose error at each gantry angle in Figure 3 is defined as 100 × [MUMeas – 
MUPlan]/MUTotal, where MUTotal is the total cumulative MU for the arc. The largest relative dose error 
at any gantry angle was 0.8% for the Maximum Inertia test (see Figure 3 (c)) and 0.25% for all other 
tests. The same analysis was performed using fractional dose recorded by log files. In Dose Test 2, a 
1˚ synchronisation error between the linac output and gantry angle was introduced by editing the 335 
planned control points from 60˚ to 180˚.  
 
Figure 3:  Relative dose error as a function of gantry angle computed using time-resolved EPID 
imaging and Dynalog files for the same delivery of (a) Dose Test 1, (b) Dose Test 2, (c) Dose Test 3 
and (d) Dose Test 4. Each of these plans consist of both clockwise and counter-clockwise arcs, 340 
however, this figure only gives results for the clockwise case for clarity.  
III.A.2 DR and GS during VMAT 
Figure 4 shows an example of the DR and GS as a function of gantry angle for Dose Test 3. 
Measurements of DR and gantry angle are given using both the EPID and log files. 
 345 
Figure 4: Example of measured (a) DR and (b) GS during the clockwise arc of Dose Test 3: 
maximum inertia. Results are plotted based on EPID imaging and Dynalog files. 
III.A.3 Beam profile constancy during VMAT 
The maximum change in OAR (OARmax) in the X and Y direction was measured as a function of 
gantry angle for all test plans. Figure 5 (a) and (c)  shows the X and Y OARmax versus gantry angle for 350 
Dose Test 1 where each data point represents the average of 10 image frames. Similarly, Figure 5 (b) 
and (d) gives a plot of the X and Y OARmax for Dose Test 2. Here each point represents the average 
profile of all images in each 30˚ arc segment, where each 30˚ segment of the plan contains a different 
combination of DR and GS as detailed in Table 1. The data points contained within the dashed circles 
correspond to segments where the nominal DR was at a minimum and the GS was at a maximum (see 355 
Table 1). 
 
Figure 5: Maximum difference in OAR as a function of gantry angle for X and Y beam profiles. 
Results are given here for Dose Test 1 ((a) and (c)) where the DR and GS are constant and Dose Test 
2 ((b) and (d)) where the DR and GS were changed every 30˚.  360 
III.B.  MLC Test Results 
III.B.1.  MLC positioning accuracy 
The overall MLC positional accuracy during the delivery of each dynamic MLC test plan is 
summarised in Figure 6, which shows a histogram of the differences between the planned and 
measured MLC positions for MLC Test 1, 2 and 3. The histograms include all MLC leaves and both 365 
clockwise and counter-clockwise deliveries of each test. 
 Figure 6: Histogram of differences between the planned MLC positions and (a) EPID measurements 
and (b) Dynalog files for MLC Test 1: sliding window, MLC Test 2: interdigitating sliding window 
and MLC Test 3: clinical VMAT. A 0.25 mm bin-width was use to partition the data. 370 
To assess the performance of each MLC leaf individually, the mean error and standard deviation of 
the error was computed on a leaf-by-leaf basis for each test plan. Figure 7 shows the positional error 
measured for each leaf in MLC Tests 1, 2 and 3. Each point represents the mean of the difference 
between the measured MLC position and the planned MLC position averaged over the entire arc. The 
error bars in the plot represent the standard deviation of this difference. Each plan comprised of arcs 375 
with both clockwise and counter-clockwise gantry rotation, however, only the clockwise case for 
MLC bank A is shown here for simplicity. To demonstrate the sensitivity of this methodology MLC 
errors were simulated in MLC Test 1 (Figure 7 (a)) for leaf 20A and 40A corresponding to systematic 
and random errors respectively of magnitude 1 mm. These errors were simulated by manually editing 
the MLC positions in the DICOM plan file. 380 
 Figure 7: The mean and standard deviation of MLC positional error for each leaf of MLC Bank A for 
the clockwise delivery of (a) MLC Test 1: sliding window, (b) MLC Test 2: interdigitating sliding 
window and (c) MLC Test 3: clinical VMAT.  Errors were computed based on both EPID and 
Dynalog files. Systematic and random position errors were respectively introduced into leaf A20 and 385 
A40 respectively of MLC Test 1. 
III.B.2.  MLC gap accuracy 
MLC gap accuracy was also specifically assessed for each individual MLC leaf-pair. Figure 8 (a), (b) 
and (c) show the measured mean and standard deviation of the MLC gap errors for the clockwise 
delivery of MLC test 1, 2 and 3 respectively. The analysis was performed using measured MLC 390 
positions from EPID images and recorded MLC positions from machine log files. MLC gap errors 
were introduced into leaf-pair 21 and 41 of the DICOM plan with a magnitude of 0.4 mm and 0.6 mm 
respectively for MLC Test 1. 
  
Figure 8: The mean and standard deviation of the MLC gap error for each leaf of MLC Bank A for 395 
the clockwise delivery of (a) MLC Test 1: sliding window, (b) MLC Test 2: interdigitating sliding 
window and (c) MLC Test 3: clinical VMAT.  Systematic MLC gap errors were introduced into MLC 
Test 1.  
III.B.3. Synchronisation between MLC and gantry angle 
MLC performance was also investigated as a function of gantry angle during the delivery of each test 400 
plan. Figure 9 shows a plot of the mean MLC positioning error at each gantry angle averaged over all 
in-field MLCs for MLC Test 1. For this delivery a synchronisation error of 0.5˚ was simulated by 
editing the control points of the plan for all control points in the second half of the arc (i.e. from 0˚ to 
-180˚). 
 405 
Figure 9: Mean MLC positioning error at each gantry angle for counter-clockwise delivery of MLC 
Test 1 as measured using the EPID and recorded in Dynalog files. For this test a synchronisation error 
was introduced mid-way through the arc. 
III.B.4. MLC speed and acceleration constancy 
As described in Table 2, MLC leaves were driven at a range of constant speeds during gantry rotation 410 
within MLC Test 1 and 2. Figure 10 shows an example of the measured MLC speed for each leaf 
during arc segments with nominal speeds of (a) 5 mm/s, (b) 15 mm/s and (c) 25 mm/s. For each MLC 
leaf, speeds were measured using EPID images and calculated from log files. Note that only Bank A 
MLCs for a single clockwise delivery are given in Figure 10 as a representative sample of the results. 
 415 
Figure 10: EPID-measured and Dynalog-recorded MLC speed for each individual MLC leaf for 3 
segments of MLC Test 1 – sliding window during gantry rotation. Plots (a), (b) and (c) correspond to 
different segments of the plan with nominal MLC speeds of 5, 15 and 25 mm/s respectively.  
The planned MLC speed within each plot of Figure 10 was computed assuming the DR was at a 
maximum of 600 MU/min during the delivery of each segment (see table 2). Figure 11 shows the 420 
actual mean DR within each segment (extracted from the log files). The figure also includes a 
“predicted dose rate” which was calculated from the difference between the measured and nominal 
MLC speed. 
 Figure 11: The mean DR for each segment of MLC Test 1 computed using the dose fraction from 425 
Dynalog files. The predicted DR is also plotted which was computed using the difference between the 
nominal MLC speed and the mean measured MLC speed during each segment. The x-labels represent 
the nominal MLC speed during each of the 16 segments of MLC Test 1: sliding window with gantry 
rotation (see Table 2). 
IV. DISCUSSION 430 
Accurate dose delivery during VMAT requires precise control of GS, DR and MLC positioning as a 
function of time. A comprehensive QA program should assess not only the performance of each 
control system in isolation, but also the synchronisation between each dynamic component. In this 
study a set of test deliveries and procedures were developed to measure the following parameters as a 
function of gantry angle: dose delivery accuracy, DR constancy, beam profile constancy, GS 435 
constancy, dynamic MLC positioning accuracy, MLC speed and acceleration constancy, and 
synchronisation between gantry angle, MLC and dose. Each of these parameters was assessed during 
the delivery of a number of specially designed VMAT test plans each containing a different level of 
delivery complexity. 
QA procedures developed in the past have focused on more of an overall assessment of VMAT where 440 
each test relies on the accuracy of more than one control system.5, 6, 41 This approach is likely to be 
due to the inability of available QA devices to perform time-resolved measurements with a high 
spatial resolution. In this work, our approach has been to use time-resolved EPID imaging to isolate 
each control system of the delivery (e.g. DR, GS, MLC position and beam profile) and to evaluate 
each component individually. This enables more informative QA procedures where there is no 445 
ambiguity as to the source of any detected errors. Assessment of each VMAT control system in 
isolation is also recommended in NCS Report 24 which states: “Since the dynamic behaviour includes 
gantry and MLC motion and DR variation, tests are needed to verify each quantity separately as well 
as combined”.37  
IV.A. Output verification during VMAT 450 
The dosimetric accuracy of the delivery was evaluated during constant DR and GS (Dose Test 1), 
changing DR and GS (Dose Test 2), maximum inertia (Dose Test 3) and clinical VMAT conditions 
(Dose Test 4). Figure 3 indicates that increasing the complexity of the delivery results in larger errors 
in the dose. This is particularly evident for Dose Test 3 (i.e. the maximum inertia test), where 
cumulative dose errors greater than 0.5% are observed intermittently at some gantry angles. For all 455 
other test plans EPID and log file-based dose measurements agree with the planned dose within 
±0.25% for all gantry angles. During Dose Test 2 (see Figure 3 (b)) regions of lower dose stability are 
observed in some segments. Table 1 shows that these segments are delivered with low GS and 
maximum DR indicating that the dose control system is less accurate for this combination of DR and 
GS. 460 
A systematic offset of approximately ~0.1% was observed between EPID and log file-based dose 
measurements for Dose Test 2 and 4. The cause of this offset may be due to the fact that only a 
relative dose fraction is recorded in the log files, in contrast to the EPID-measured dose which is 
converted to absolute MU using a calibration image. Some other potential causes of this small offset 
are EPID imaging artefacts such as gain-ghosting, image lag and DR dependence. The time-varying 465 
DR and GS were plotted individually for Dose Test 3 (see Figure 4) to determine the source of the 
observed dose errors. Figure 4 shows that the dose errors correspond to synchronised rapid changes in 
both GS and DR, which indicates that the errors may be due to inertia of the gantry. At these points in 
the delivery, the gantry is required to change velocity faster than possible which results in a transient 
dosimetric error as seen in Figure 3(c). This example illustrates the advantages of directly measuring 470 
each individual component of the delivery so that the source of dose discrepancies can be determined.  
The QA procedures were found to be sensitive to simulated errors as seen in Figure 3 (b) where a 1˚ 
synchronisation offset was introduced into Dose Test 2. This type of error was chosen as it illustrates 
the sensitivity of this method to gantry angle synchronisation errors which may not be detected by 
traditional QA procedures which rely on integrated EPID imaging or film measurements.11 An 475 
example of such a test is the popular Ling Test 2,5 where integrated dose is assessed and no 
measurement is performed to ensure the dose is delivered at the correct gantry angle. Note that, the 
magnitude of the simulated errors (both MLC and dose) approximate the minimum detectable error 
using this system.  
IV.B. Beam profile constancy during VMAT 480 
Profile constancy was assessed as a function of gantry angle. The EPID-measured profiles were not 
directly related to the actual beam profile flatness and symmetry in water, due to off-axis energy 
response and the nature of the flood-field correction.42 Rather, the profiles measured at each gantry 
angle were compared to baseline profiles at gantry 0˚ using an off-axis ratio (OAR) as suggested in 
AAPM TG 142.43 Dose Test 1 (Figure 5 (a) and (c)) indicates that there is no substantial variation in 485 
profile constancy as a function of gantry angle for deliveries where the GS and DR was constant. 
Dose Test 2 (Figure 5 (b) and (d)) shows that beam profiles were found to be less stable in segments 
with low DR and high GS compared to other segments. Note that, the accuracy of X profile 
measurements using the EPID is extremely high due to the fast readout time of each row of the 
imager, high spatial resolution and high reproducibility of each pixel response. For the Y profile, 490 
rapid changes in dose rate can reduce the accuracy of the measurement as discussed in section II.C.1. 
IV.C. MLC positioning accuracy 
MLC positioning accuracy was measured for dynamic MLCs under a range of conditions. In terms of 
the overall leaf positioning accuracy, no differences were observed between sliding gap MLC patterns 
with and without friction/interdigitation (see Figure 6). In general, leaf positioning during the clinical 495 
VMAT delivery (MLC Test 3) was found to be more accurate than the test patterns in MLC Test 1 
and 2. This is expected as these tests were designed to represent the most complex MLC trajectories 
(in terms of speed and acceleration) that could occur in a clinical plan. 
The performance of each individual MLC leaf was evaluated using the mean and standard deviation 
of the MLC positioning error averaged over the entire arc (see Figure 7). Simulated errors in leaf 20A 500 
and 40A for MLC Test 1 show that this methodology is capable of detecting single MLC leaf errors as 
small as 1 mm and can be used to determine the type (e.g. random or systematic) and magnitude of 
detected errors. The types of MLC errors simulated were chosen as they represent realistic clinical 
MLC positioning errors which have been demonstrated by other groups,16, 24 for example MLC 
calibration errors (systematic offsets) and MLC motor failures (random positioning errors). 505 
IV.D. MLC gap accuracy 
In addition to mean positioning error, leaf gap errors were also measured for each MLC of each test 
plan as shown in Figure 8. A larger deviation in gap error was seen for the clinical delivery (MLC 
Test 3), where gap between opposing leaf-pairs is changing rapidly, compared to MLC Test 1 and 2, 
where the gap is fixed during the delivery. MLC gap errors were simulated in MLC Test 1 and 510 
detection and classification of errors as small as 0.4 mm was demonstrated (see Figure 8 (a)). Note 
that, the reason for specifically assessing the average gap error for each leaf pair is that these types of 
errors have been shown to produce the largest systematic dose delivery errors during clinical VMAT 
deliveries.44 
IV.E. Synchronisation between MLC and gantry angle 515 
MLC performance was also assessed as function of gantry angle to identify any gantry angle 
dependency and detect synchronisation errors between the MLC and gantry angle control systems. 
Figure 9 shows the mean MLC positioning error versus gantry angle averaged over all MLC leaves 
for MLC Test 1. For this example, a synchronisation error between MLC and gantry angle of 0.5˚ was 
introduced at 0˚ to -180˚. An error such as this could not be detected using traditional MLC QA 520 
procedures for VMAT, for example the picket fence test proposed by Ling et al.5 which was not 
designed to determine whether MLCs reach the correct position at the desired gantry angle.11 Another 
limitation of the picket fence test proposed by Ling et al. is that the MLC trajectories are less complex 
than those present in a typical clinical VMAT plan. Firstly, the MLCs are static when forming the 
“pickets” in the integrated image which means that only static MLC positioning accuracy is evaluated. 525 
Secondly, the test does not incorporate any changes in direction during gantry rotation which is an 
additional complexity in VMAT compared to IMRT and should be specifically assessed.  
It can also be observed that there is a difference between the mean errors measured by the EPID and 
by the Dynalog, particularly on the range of 0-60˚. These differences are due to the method for 
assigning a gantry angle from the OBI system to each EPID. As the MV and OBI systems operate at 530 
different frame rates this translates into a sampling error in the gantry angle and produces the 
oscillation seen in the EPID-measured leaf accuracy in Figure 9 which is accentuated on the range of 
0-60˚ when the MLC speed is high.  
IV.F. MLC speed and acceleration constancy 
MLC speed constancy was addressed within MLC Test 1 and 2 by driving MLC leaves at five 535 
different constant speeds during segments of each arc delivery. Figure 10 shows an example of the 
measured MLC speed using EPID and log files for each MLC compared to the nominal speed for 
three of these segments during MLC Test 1. Both log files and EPID measurements indicate that the 
MLCs are travelling slower than their desired speed for all segments. This may result in a dosimetric 
error if the slower MLC speeds are not compensated for by lower DR s. A “predicted dose rate” could 540 
be computed using the difference between the nominal and measured MLC speed, which is the DR 
required to compensate for the slower MLC speeds in each segment. In Figure 11, this “predicted 
dose rate” is compared to the “actual dose rate” from log files for each segment. Figure 11 shows that 
in segments where the average DR is lower than the nominal DR of 600 MU/min (for example 570 
MU/min in segment 10) the MLC speed is also lowered by the control system to a speed that would 545 
ensure the correct dose is delivered.  
For all dosimetry and MLC tests, there was no significant difference in machine performance 
observed between clockwise and counter-clockwise rotations. 
IV.G. Time efficiency and limitations 
As treatment techniques increase in complexity, the required time and operational costs of additional 550 
quality management procedures also increases. This is discussed in the report from AAPM TG4045 
and more recently in AAPM TG100.46 The latter report states that “labour intensive activities place a 
heavy demand on medical physicists” and that “mental and physical overload have been linked to 
serious errors in many radiation therapy related incidents and accidents”. While it is ideal to perform 
QA tests that are comprehensive and of the highest standards, this must be balanced with the 555 
additional time and resources required to correctly and competently perform each test. Automation of 
modern QA techniques is paramount to achieving this balance in order to reduce the excessive 
demands on physics resources resulting from the increasing number and intensity of recommended 
QA tests. In this work, the deliveries are performed without the presence of a phantom which 
eliminates setup time and the analysis of acquired data is completely automated. The delivery of the 560 
test suite, which was designed as a commissioning or annual set, can be performed within 1 hour 
including setup time, calibration images and repeated clockwise and counter-clockwise deliveries. 
The efficiency of this process is a clear advantage over other more labour intensive QA 
methodologies for example those which rely on film or detector array measurements within a 
phantom. 565 
A potential limitation in the use of EPID image frames acquired using the frame grabber, is the 
reliance on the gantry angle from the header of the EPID images. In this method, the header gantry 
angle is read out from the on-board OBI system and so is not entirely independent of the linac. 
Therefore, this gantry angle should not be relied on for QA purposes without being independently 
verified. The authors recommend that the EPID header gantry angle be compared to an independent 570 
gantry angle measurement on a regular basis to ensure it is a true indication of the correct gantry 
angle. This may be done using one of the many available dynamic gantry angle measurement tools27, 
30, 47 or manually using a level as part of a regular quality control program. 
II.H.  Machine log file analysis 
In general, measurements performed by the EPID agreed with information recorded by the machine 575 
log files. The EPID-measured parameters gave a larger standard deviation in errors when compared to 
log files however the mean errors were comparable.  
Despite the lower standard deviation of log files and the reasonable agreement with EPID in this 
study, it is not recommended to rely solely on log files as the readout is sourced directly from the 
linac control system. In particular, care should be taken when using log files for MLC QA as the 580 
positions recorded may not reflect the actual location of the MLCs as other authors have 
demonstrated. 16, 23, 24 Note that in this study the log file analysis appeared to be sensitive to delivery 
errors introduced into Dose Test 2 and MLC Test 1, however this is due to the fact that errors were 
introduced into the DICOM plan file rather than the MLC, gantry angle or dose calibration. As the 
EPID measurements are a direct independent measurement of the MLC-defined radiation field and 585 
output  they are not subject to the same inadequacies as log files and may be used as a gold standard 
for both MLC and dose delivery accuracy.  
V. CONCLUSION 
A set of VMAT test plans and analysis software has been developed to systematically assess the 
performance of all components of VMAT deliveries individually and as a function of gantry angle. 590 
The procedures have been shown to be sensitive to a range of delivery errors including random and 
systematic MLC errors, dose output errors and synchronisation errors. The methodology relies solely 
on time-resolved EPID imaging without the presence of a phantom and analysis of acquired image 
data was fully automated. The procedures developed in this work are both comprehensive and time-
efficient and can be used for streamline gantry-resolved commissioning and QA of VMAT delivery 595 
systems.  
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